HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NB 506

an indolocarbazole antitumor agent; structure given in first source; a DNA topoisomerase I inhibitor
Also Known As:
6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione; NB-506
Networked: 18 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bailly, C: 3 articles (09/2001 - 01/2001)
2. Tazi, J: 1 article (09/2001)
3. Pilch, B: 1 article (09/2001)
4. Allemand, E: 1 article (09/2001)
5. Riou, J F: 1 article (09/2001)
6. Soret, J: 1 article (09/2001)
7. Facompré, M: 1 article (09/2001)
8. Arakawa, H: 1 article (04/2001)
9. Hara, Y: 1 article (04/2001)
10. Nishimura, S: 1 article (04/2001)

Related Diseases

1. Neoplasms (Cancer)
2. Fibrosarcoma
3. Carcinoma (Carcinomatosis)
4. Poisoning
5. Leukemia

Related Drugs and Biologics

1. Camptothecin
2. Type I DNA Topoisomerases (Topoisomerase I)
3. DNA (Deoxyribonucleic Acid)
4. carbazole
5. Glycoproteins (Glycoprotein)
6. edotecarin (J 107088)
7. Topoisomerase I Inhibitors
8. Protein Kinase Inhibitors
9. Messenger RNA (mRNA)
10. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Injections
2. Drug Therapy (Chemotherapy)